drugset / Trial / NCT05601336
of Sodium Glucose Cotransporter-2 Inhibitors on Metabolic, Hormonal and Clinical Parameters in PCO
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of this study is to compare the hormonal, metabolic and clinical effects of metformin and dapagliflozin as monotherapies and the effect of both of them as a combined therapy in infertile women with PCOs.
Timeline
- Start
- 2022-01-15
- Primary completion
- 2023-07-30
- Completion
- 2023-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dapagliflozin | Small molecule | 5 mg | — |
| Comparator | Dapagliflozin/Metformin | Unknown | — | — |
| Comparator | Metformin | Small molecule | 1000 mg | — |
Indications
No indication recorded.